Literature DB >> 30420403

Beyond fat accumulation, NAFLD genetics converges on lipid droplet biology.

Guido Baselli1, Luca Valenti2,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30420403      PMCID： PMC6314259          DOI： 10.1194/jlr.C091116

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  9 in total

Review 1.  Genetics and epigenetics of NAFLD and NASH: Clinical impact.

Authors:  Mohammed Eslam; Luca Valenti; Stefano Romeo
Journal:  J Hepatol       Date:  2017-11-06       Impact factor: 25.083

2.  17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.

Authors:  Yanling Ma; Olga V Belyaeva; Philip M Brown; Koji Fujita; Katherine Valles; Suman Karki; Ynto S de Boer; Christopher Koh; Yanhua Chen; Xiaomeng Du; Samuel K Handelman; Vincent Chen; Elizabeth K Speliotes; Cara Nestlerode; Emmanuel Thomas; David E Kleiner; Joseph M Zmuda; Arun J Sanyal; Natalia Y Kedishvili; T Jake Liang; Yaron Rotman
Journal:  Hepatology       Date:  2019-03-05       Impact factor: 17.425

3.  Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease.

Authors:  Carlos J Pirola; Martin Garaycoechea; Diego Flichman; Marco Arrese; Julio San Martino; Carla Gazzi; Gustavo O Castaño; Silvia Sookoian
Journal:  J Lipid Res       Date:  2018-10-15       Impact factor: 5.922

4.  A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.

Authors:  Noura S Abul-Husn; Xiping Cheng; Alexander H Li; Yurong Xin; Claudia Schurmann; Panayiotis Stevis; Yashu Liu; Julia Kozlitina; Stefan Stender; G Craig Wood; Ann N Stepanchick; Matthew D Still; Shane McCarthy; Colm O'Dushlaine; Jonathan S Packer; Suganthi Balasubramanian; Nehal Gosalia; David Esopi; Sun Y Kim; Semanti Mukherjee; Alexander E Lopez; Erin D Fuller; John Penn; Xin Chu; Jonathan Z Luo; Uyenlinh L Mirshahi; David J Carey; Christopher D Still; Michael D Feldman; Aeron Small; Scott M Damrauer; Daniel J Rader; Brian Zambrowicz; William Olson; Andrew J Murphy; Ingrid B Borecki; Alan R Shuldiner; Jeffrey G Reid; John D Overton; George D Yancopoulos; Helen H Hobbs; Jonathan C Cohen; Omri Gottesman; Tanya M Teslovich; Aris Baras; Tooraj Mirshahi; Jesper Gromada; Frederick E Dewey
Journal:  N Engl J Med       Date:  2018-03-22       Impact factor: 91.245

Review 5.  Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease.

Authors:  Serena Pelusi; Luca Valenti
Journal:  Liver Int       Date:  2018-10-17       Impact factor: 5.828

6.  Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.

Authors:  Elizabeth K Speliotes; Laura M Yerges-Armstrong; Jun Wu; Ruben Hernaez; Lauren J Kim; Cameron D Palmer; Vilmundur Gudnason; Gudny Eiriksdottir; Melissa E Garcia; Lenore J Launer; Michael A Nalls; Jeanne M Clark; Braxton D Mitchell; Alan R Shuldiner; Johannah L Butler; Marta Tomas; Udo Hoffmann; Shih-Jen Hwang; Joseph M Massaro; Christopher J O'Donnell; Dushyant V Sahani; Veikko Salomaa; Eric E Schadt; Stephen M Schwartz; David S Siscovick; Benjamin F Voight; J Jeffrey Carr; Mary F Feitosa; Tamara B Harris; Caroline S Fox; Albert V Smith; W H Linda Kao; Joel N Hirschhorn; Ingrid B Borecki
Journal:  PLoS Genet       Date:  2011-03-10       Impact factor: 5.917

7.  PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.

Authors:  Carlo Pirazzi; Luca Valenti; Benedetta Maria Motta; Piero Pingitore; Kristina Hedfalk; Rosellina Margherita Mancina; Maria Antonella Burza; Cesare Indiveri; Yvelise Ferro; Tiziana Montalcini; Cristina Maglio; Paola Dongiovanni; Silvia Fargion; Raffaela Rametta; Arturo Pujia; Linda Andersson; Saswati Ghosal; Malin Levin; Olov Wiklund; Michelina Iacovino; Jan Borén; Stefano Romeo
Journal:  Hum Mol Genet       Date:  2014-03-25       Impact factor: 6.150

8.  Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.

Authors:  P Dongiovanni; S Stender; A Pietrelli; R M Mancina; A Cespiati; S Petta; S Pelusi; P Pingitore; S Badiali; M Maggioni; V Mannisto; S Grimaudo; R M Pipitone; J Pihlajamaki; A Craxi; M Taube; L M S Carlsson; S Fargion; S Romeo; J Kozlitina; L Valenti
Journal:  J Intern Med       Date:  2017-12-27       Impact factor: 8.989

9.  Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.

Authors:  Paola Dongiovanni; Marica Meroni; Rosellina M Mancina; Guido Baselli; Raffaela Rametta; Serena Pelusi; Ville Männistö; Anna L Fracanzani; Sara Badiali; Luca Miele; Stefania Grimaudo; Salvatore Petta; Elisabetta Bugianesi; Giorgio Soardo; Silvia Fargion; Jussi Pihlajamäki; Stefano Romeo; Luca Valenti
Journal:  Hepatol Commun       Date:  2018-04-25
  9 in total
  4 in total

1.  Building bridges: PCSK7 as a NAFLD candidate gene connecting hepatic inflammation with hypertriglyceridemia.

Authors:  Rotonya M Carr; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2019-04-25       Impact factor: 5.922

Review 2.  Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology.

Authors:  Mohammed Eslam; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-10-22       Impact factor: 46.802

3.  Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Bishuang Cai; Paola Dongiovanni; Kathleen E Corey; Xiaobo Wang; Igor O Shmarakov; Ze Zheng; Canan Kasikara; Viralkumar Davra; Marica Meroni; Raymond T Chung; Carla V Rothlin; Robert F Schwabe; William S Blaner; Raymond B Birge; Luca Valenti; Ira Tabas
Journal:  Cell Metab       Date:  2019-12-12       Impact factor: 27.287

4.  TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease.

Authors:  Huan Zhou; Xingyu Zhu; Yan Yao; Yue Su; Jing Xie; Minhui Zhu; Cuixia He; Jiaxiang Ding; Yuanyuan Xu; Rongfang Shan; Ying Wang; Xiangdi Zhao; Yuzhou Ding; Bingyan Liu; Zhonghuan Shao; Yuanyuan Liu; Tao Xu; Yunqiu Xie
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.